| abstract |
The present invention provides novel β 2 adrenergic receptor agonist compounds. The present invention also includes pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β 2 adrenergic receptor activity, and for preparing such compounds. Provides useful processes and intermediates. The compounds of the present invention have been found to be potent and selective β 2 adrenergic receptor agonists. Furthermore, the compounds of the present invention have been found to have a surprising and unexpected long duration of action, which allows for once or even less frequent dosing. |